Ibuprofen and sertraline
Pro Research Analysisby 
Searched over 200M research papers
Ibuprofen and Sertraline: Drug-Drug Interactions and Clinical Implications
Introduction to Ibuprofen and Sertraline Interactions
The concurrent use of ibuprofen, a common over-the-counter (OTC) anti-inflammatory drug, and sertraline, a selective serotonin reuptake inhibitor (SSRI) used to treat depression and anxiety, is prevalent due to the comorbidity of pain and mental health disorders. Understanding the interactions between these drugs is crucial for optimizing treatment efficacy and minimizing adverse effects.
Impact on Plasma Concentrations
Research indicates that while metamizole significantly reduces the plasma concentration of sertraline, ibuprofen does not exhibit the same effect. This finding is essential for clinicians when considering pain management options for patients on sertraline, as ibuprofen may be a safer choice in terms of maintaining therapeutic levels of the antidepressant1.
Adverse Events and Pharmacokinetic Interactions
A retrospective chart review of adverse events associated with the interaction between antidepressants and OTC drugs revealed that ibuprofen, when used with sertraline, can lead to QTc prolongation, a measure of delayed heart repolarization that can increase the risk of arrhythmias. This highlights the importance of monitoring cardiac function in patients using both medications concurrently3. Additionally, the review identified that pharmacokinetic interactions between ibuprofen and sertraline could exacerbate side effects, emphasizing the need for careful patient monitoring3.
Mechanisms of Interaction
The interaction between ibuprofen and sertraline may involve complex mechanisms. One study demonstrated that both drugs could influence the release of neurotrophic factors from platelets. Specifically, ibuprofen and sertraline were found to reduce the release of nerve growth factor (NGF) in a calcium-dependent manner, which could have implications for their combined use in treating conditions associated with inflammation and neurodegeneration4.
Broader Implications for Drug-Drug Interactions
A novel algorithm for analyzing drug-drug interactions (DDIs) from MEDLINE literature has shown high accuracy in identifying potential interactions between ibuprofen and sertraline. This method underscores the importance of leveraging computational tools to predict and manage DDIs effectively, ensuring patient safety and optimizing therapeutic outcomes2.
Conclusion
The concurrent use of ibuprofen and sertraline requires careful consideration due to potential pharmacokinetic interactions and adverse effects. While ibuprofen does not significantly alter sertraline plasma levels, it can lead to QTc prolongation and other side effects. Clinicians should monitor patients closely and consider these interactions when prescribing these medications together. Advances in computational analysis of DDIs offer promising tools for better understanding and managing these complex interactions.
Sources and full results
Most relevant research papers on this topic
Metamizole but not ibuprofen reduces the plasma concentration of sertraline: Implications for the concurrent treatment of pain and depression/anxiety disorders
Metamizole reduces sertraline plasma concentrations, potentially impacting the concurrent treatment of pain and depression/anxiety disorders.
Non-RCT
Very Rigorous JournalA novel algorithm for analyzing drug-drug interactions from MEDLINE literature
Our algorithm accurately detects drug-drug interactions from MEDLINE literature, with high accuracy for warfarin, ibuprofen, furosemide, and sertraline.
Unprescribed and unnoticed: Retrospective chart review of adverse events of interactions between antidepressants and over-the-counter drugs
Pharmacokinetic interactions between over-the-counter drugs and antidepressants may increase the concentration and severity of side effects.
Observational StudyAntidepressants and Anti-Inflammatory Drugs Differentially Reduce the Release of NGF and BDNF from Rat Platelets
Antidepressants and anti-inflammatory drugs differentially influence the release of NGF and BDNF from rat platelets, with a time-, dose-, and calcium-specific pattern.
Non-RCT
Animal StudyTarget Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection
Four chemically divergent drugs inhibit Ebolavirus infection by directly binding to the virus glycoprotein and destabilizing its prefusion conformation.
In Vitro StudySertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial.
Sertraline significantly decreased serum levels of IL-6 in hemodialysis patients with depression, suggesting it could be a promising strategy to reduce systemic inflammation and treat depression in these patients.
RCT
Highly CitedSafety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.
Sertraline may improve depression response and cardiac prognosis in patients with chronic heart failure.
RCT
Large Human TrialHighly CitedSertraline: a review of its use in the management of major depressive disorder in elderly patients.
Sertraline is an effective and well-tolerated antidepressant for elderly patients with major depressive disorder, offering benefits over nortriptyline and fluoxetine without affecting antidepressant effects.
Literature ReviewReview of sertraline in post-traumatic stress disorder
Sertraline is a first-line treatment for PTSD due to its proven efficacy, improved tolerability, and low risk of lethality in overdose compared to older antidepressants.
Systematic ReviewPharmacology of sertraline: a review.
Sertraline, a selective serotonin reuptake blocker, shows potential antidepressant activity without side effects and may have broader clinical indications for body weight and obsessive-compulsive disorder.
Literature Review